Li, Li
Lin, Ling
Veeraraghavan, Jamunarani
Hu, Yiheng
Wang, Xian
Lee, Sanghoon
Tan, Ying
Schiff, Rachel
Wang, Xiao-Song
Funding for this research was provided by:
National Institutes of Health (1R01 CA181368, 1R01 CA183976)
Article History
Received: 15 October 2019
Accepted: 27 July 2020
First Online: 8 August 2020
Ethics approval and consent to participate
: All animal experiments were performed in accordance with the institutional guidelines and regulations, and the animal protocol was approved by the BCM Institutional Animal Care and Use Committee (Approval # AN-6123).
: Not applicable.
: Dr. Rachel Schiff receives research funding from AstraZeneca, GlaxoSmithKline, Gilead Sciences, and PUMA Biotechnology, outside of this project, and is a consulting/advisory committee member for Macrogenics and, in the past, forĀ Eli Lilly. The other coauthors do not have competing financial interests.